Protein kinase C-beta inhibition for diabetic kidney disease.
about
Diabetic kidney disease: from physiology to therapeuticsStore-operated calcium entry and diabetic complicationsTherapeutic Modalities in Diabetic Nephropathy: Future Approaches.Molecular mechanisms of diabetic vascular complicationsEffects of vitamin D on renal fibrosis in diabetic nephropathy model ratsActivation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelProtein kinase Cβ2 inhibition reduces hyperglycemia-induced neural tube defects through suppression of a caspase 8-triggered apoptotic pathway.Risk for ESRD in type 1 diabetes remains high despite renoprotection.Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetesPathophysiological role and therapeutic implications of inflammation in diabetic nephropathyProtein kinase C, an elusive therapeutic target?Requirement for active glycogen synthase kinase-3β in TGF-β1 upregulation of connective tissue growth factor (CCN2/CTGF) levels in human gingival fibroblasts.Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.Probing the biology of natural products: molecular editing by diverted total synthesis.Oxidative stress and diabetic kidney disease.Atypical protein kinase C in cell motility.Vitamin D receptor gene polymorphisms in association with diabetic nephropathy: a systematic review and meta-analysis.Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
P2860
Q27021392-AF5741E3-C342-4004-8698-D9A9ED58109CQ28085037-6131B278-56C7-4A0E-81F0-9EB844A62B48Q30423005-6F53D9E1-C07C-4BB4-9364-54CF9D14D360Q33558421-C818ECCA-B51E-4691-9DD9-6E8E7130F28AQ33898491-101D689F-823D-41C6-9E27-FF0E2D48CCD6Q34171206-310A8996-6CD1-4A15-9A98-287A21D4F27AQ34653233-753364C4-40DE-452E-9640-6A910B6BCE01Q34673067-3B06B356-A5F5-4A72-A376-368B14D7A82FQ34695426-A93C50AE-8450-43E2-A4CF-04F678692CDCQ35159419-0DE4F621-F762-413D-ACB5-640492C83D2DQ35673446-4C175A44-D0C8-45C9-A5C8-ABBA6DC86A4EQ37141320-3A2AC0C4-4E97-450E-838B-9BD844432F0DQ37142420-FB80152E-5C91-4A1A-B853-69810A347E79Q37482925-C6BD5DF3-86EB-428E-B20E-E7C5AAE5AE02Q37809500-AA6E60A6-7690-4084-97AA-ABC5BBE35A35Q37873829-5E6AE904-C6BC-41ED-A095-B1B55DA65EF9Q38055397-C355B0CF-BBD0-4331-83E1-04FF8180E4ABQ38368499-2D989CCB-9EAC-4648-8C35-2127EA15A79AQ40053242-A7A9D688-9727-423D-B891-2BCB28F9FB38Q45141864-4DDD4A7D-88BF-4F31-9A62-967EDC0BFFD2
P2860
Protein kinase C-beta inhibition for diabetic kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Protein kinase C-beta inhibition for diabetic kidney disease.
@en
Protein kinase C-beta inhibition for diabetic kidney disease.
@nl
type
label
Protein kinase C-beta inhibition for diabetic kidney disease.
@en
Protein kinase C-beta inhibition for diabetic kidney disease.
@nl
prefLabel
Protein kinase C-beta inhibition for diabetic kidney disease.
@en
Protein kinase C-beta inhibition for diabetic kidney disease.
@nl
P1476
Protein kinase C-beta inhibition for diabetic kidney disease.
@en
P2093
Katherine R Tuttle
P356
10.1016/J.DIABRES.2008.09.041
P478
82 Suppl 1
P577
2008-11-01T00:00:00Z